@Rorbag
It is likely due to the fact that they have already cleared the software for AS. I believe this was touched on in a recent webinar. When they sought FDA approval for AS the FDA were seeing the tech for the first time surely resulting in a more rigorous approval process. It's the same software for HF, works the same way, just different data points. If they have the study to back it up then the approval process is really just a formality.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $138.7M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 20.5¢ | $321.5K | 1.516M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 212563 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 400412 | 5 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |